Charles River Laboratories has acquired Accugenix, a provider of cGMP-compliant contract microbial identification testing, for approximately $17 million in cash. This acquisition strengthens Charles River’s Endotoxin and Microbial Detection (EMD) portfolio of products and services, providing clients with “state-of-the-art microbial detection services for manufacturing in the biopharmaceutical, medical device, nutraceutical and consumer care industries,” according to a company stateme...